Farther Finance Advisors, LLC

Position in EW — Edwards Lifesciences Corp

CIK 1992825 SAN FRANCISCO, CA

Position in EW

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$1,124,243

-$11,542 QoQ

Shares Held

14,039

+5.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $25,381,241 across 88 Medical Devices names. EW ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	72,818	$7,476,224
2	SYK	Stryker Corp	17,084	$5,613,631
3	MDT	Medtronic plc	59,342	$5,141,984
4	BSX	Boston Scientific Corp	22,272	$1,397,568
5	EW	Edwards Lifesciences Corp This page	14,039	$1,124,243
6	STE	STERIS plc	3,208	$709,385
7	GEHC	GE HealthCare Technologies Inc.	9,046	$643,894
8	DXCM	Dexcom Inc	9,960	$625,488

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,124,243	14,039	+5.4%	Shares	Sole	2026-04-07
2025-12-31	$1,135,785	13,323	+8.2%	Shares	Sole	2026-01-23
2025-09-30	$957,737	12,315	+12.4%	Shares	Sole	2025-10-14
2025-06-30	$856,712	10,954	+24.4%	Shares	Sole	2025-07-11
2025-03-31	$638,403	8,808	+390.7%	Shares	Sole	2025-04-14
2024-12-31	$132,883	1,795	-41.7%	Shares	Sole	2025-02-10
2024-09-30	$203,315	3,081	-51.7%	Shares	Sole	2024-10-29
2024-06-30	$589,597	6,383	+344.5%	Shares	Sole	2024-07-31
2024-03-31	$137,224	1,436	+45.3%	Shares	Sole	2024-05-14
2023-12-31	$75,335	988	+34.8%	Shares	Sole	2024-02-15
2023-09-30	$50,782	733	+61.5%	Shares	Sole	2023-11-14
2023-06-30	$42,825	454	+10.7%	Shares	Sole	2024-05-14
2023-03-31	$33,919	410	+22.4%	Shares	Sole	2024-05-14
2022-12-31	$24,994	335	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.